Sun's Cardene ANDA Infringes EKR Patent: Judge

Law360, New York (April 1, 2009, 12:00 AM EDT) -- A judge has ruled that generic-drug maker Sun Pharmaceutical Industries Inc. would infringe a patent on EKR Therapeutics Inc.'s intravenous high blood pressure drug Cardene if it were allowed to market a generic version of the drug.

Judge Katharine S. Hayden of the U.S. District Judge for the District of New Jersey on Tuesday granted a motion for summary judgment of infringement by EKR, finding that Sun could not avoid infringing the patent by simply making a more concentrated drug than Cardene and requiring doctors to...
To view the full article, register now.